Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Structure-based Drug Design Methods

Figure 28-1 Dorzolamide (Trusopt). the first FDA-approved drug to be designed by structure-based methods, is a carbonic anhydrase inhibitor that is used to lower ocular pressure in glaucoma patients.

Sperandio, O., Miteva, M.A., and Villoutreix, B.O. (2008) Combining ligand and structure-based methods in drug design projects. Current Computer-Aided Drug Design, 4, 250-258. [Pg.463]

See other pages where Structure-based Drug Design Methods is mentioned: [Pg.471] [Pg.405] [Pg.114] [Pg.32] [Pg.35] [Pg.53] [Pg.66] [Pg.55] [Pg.150] [Pg.306] [Pg.59] [Pg.79] [Pg.336] [Pg.241] [Pg.1] [Pg.202] [Pg.2] [Pg.268] [Pg.166] [Pg.418] [Pg.426] [Pg.4014] [Pg.4] [Pg.58] [Pg.290] [Pg.111] [Pg.245] [Pg.412] [Pg.171] [Pg.233] [Pg.2590] [Pg.196] [Pg.164] [Pg.187] [Pg.1606] [Pg.2762] [Pg.151] [Pg.597] [Pg.606] [Pg.695] [Pg.709] [Pg.5] [Pg.69] [Pg.351] [Pg.361] [Pg.364] [Pg.364] [Pg.25] [Pg.278]

SEARCH

Based Drug Design

Design Bases

Design methods

Design methods method

Design structures

Designing method

Drug design protein structure-based methods

Drug structure

Drug structure-based

Structural methods

Structure based design

Structure designable

Structure drug design

Structure-based drug design